BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17588831)

  • 1. Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate ON 01910.Na, a mitotic progression modulator, in human plasma.
    Li J; Zhao M; Jimeno A; He P; Ramana Reddy MV; Hidalgo M; Donehower RC; Rudek MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):198-204. PubMed ID: 17588831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate aminoflavone (NSC 686288) in human plasma.
    Wiegand R; Wu J; Sha X; LoRusso P; Heath E; Li J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(14-15):1460-4. PubMed ID: 19349217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a liquid chromatography/tandem mass spectrometry method for the determination of DMXAA in human and mouse plasma.
    Zhang X; Zhao M; Rudek MA; He P; Vogelstein B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):217-22. PubMed ID: 17307035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid and sensitive method for determination of sorafenib in human plasma using a liquid chromatography/tandem mass spectrometry assay.
    Zhao M; Rudek MA; He P; Hafner FT; Radtke M; Wright JJ; Smith BD; Messersmith WA; Hidalgo M; Baker SD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):1-7. PubMed ID: 16798122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate ABT-751, ABT-751 glucuronide, and ABT-751 sulfate in human plasma for clinical pharmacology studies.
    Rudek MA; Zhao M; He P; Messersmith WA; Baker SD
    J Pharm Biomed Anal; 2006 Sep; 42(2):253-60. PubMed ID: 16765012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of ABT-888, a poly (ADP-ribose) polymerase inhibitor, and its metabolite in human plasma by liquid chromatography/tandem mass spectrometry.
    Wiegand R; Wu J; Sha X; LoRusso P; Li J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(3-4):333-9. PubMed ID: 20005184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and clinical application of an LC-ESI-MS/MS method for simultaneous determination of tolmetin and MED5, the metabolites of amtolmetin guacil in human plasma.
    Hotha KK; Bharathi DV; Kumar SS; Reddy YN; Chatki P; Ravindranath LK; Veera KN; Mullangi R
    Biomed Chromatogr; 2010 Oct; 24(10):1100-7. PubMed ID: 20853464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A liquid chromatography/tandem mass spectrometry assay to quantitate MS-275 in human plasma.
    Zhao M; Rudek MA; Mnasakanyan A; Hartke C; Pili R; Baker SD
    J Pharm Biomed Anal; 2007 Jan; 43(2):784-7. PubMed ID: 16971082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
    Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
    J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 96-well single-pot protein precipitation, liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of muraglitazar, a novel diabetes drug, in human plasma.
    Xue YJ; Liu J; Pursley J; Unger S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):213-22. PubMed ID: 16388995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 96-well single-pot liquid-liquid extraction, hydrophilic interaction liquid chromatography-mass spectrometry method for the determination of muraglitazar in human plasma.
    Xue YJ; Liu J; Unger S
    J Pharm Biomed Anal; 2006 Jun; 41(3):979-88. PubMed ID: 16533587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a liquid chromatography-tandem mass spectrometry for the determination of BPR0L075, a novel antimicrotuble agent, in rat plasma: application to a pharmacokinetic study.
    Chang YW; Chen WC; Lin KT; Chang L; Yao HT; Hsieh HP; Lan SJ; Chen CT; Chao YS; Yeh TK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):162-8. PubMed ID: 17005456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of esculentoside A in dog plasma by LC-MS/MS method: application to pre-clinical pharmacokinetics.
    Guan X; Chang H; Sun F; Chen X; Zhang W; Fan G
    J Pharm Biomed Anal; 2013 Jan; 72():261-6. PubMed ID: 23010600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a highly sensitive method for the determination of abiraterone in rat and human plasma by LC-MS/MS-ESI: application to a pharmacokinetic study.
    Gurav S; Punde R; Farooqui J; Zainuddin M; Rajagopal S; Mullangi R
    Biomed Chromatogr; 2012 Jun; 26(6):761-8. PubMed ID: 22002259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid chromatography/tandem mass spectrometry method for the simultaneous determination of vardenafil and its major metabolite, N-desethylvardenafil, in human plasma: application to a pharmacokinetic study.
    Ku HY; Shon JH; Liu KH; Shin JG; Bae SK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(1-2):95-100. PubMed ID: 19042162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid chromatography tandem mass spectrometry method for the quantitative analysis of ceritinib in human plasma and its application to pharmacokinetic studies.
    Heudi O; Vogel D; Lau YY; Picard F; Kretz O
    Anal Bioanal Chem; 2014 Nov; 406(28):7389-96. PubMed ID: 25258279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate dimethyl benzoylphenylurea (BPU) and its five metabolites in human plasma and urine for clinical pharmacology studies.
    Rudek MA; Zhao M; He P; Zabelina Y; Jin R; Messersmith WA; Wolff AC; Baker SD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 828(1-2):41-54. PubMed ID: 16253576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of febuxostat in human plasma.
    Wang H; Deng P; Chen X; Guo L; Zhong D
    Biomed Chromatogr; 2013 Jan; 27(1):34-8. PubMed ID: 22623034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of tadalafil in human plasma by liquid chromatography-tandem mass spectrometry with electrospray ionization.
    Ramakrishna NV; Vishwottam KN; Puran S; Koteshwara M; Manoj S; Santosh M; Chidambara J; Wishu S; Sumatha B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 809(2):243-9. PubMed ID: 15315772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a sensitive LC-MS/MS-ESI method for the determination of ivabradine in human plasma: application to a pharmacokinetic study.
    Jiang J; Tian L; Huang Y; Li Y
    Biomed Chromatogr; 2013 Dec; 27(12):1603-8. PubMed ID: 23798342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.